Clinical Trials Logo

Respiratory Distress Syndrome clinical trials

View clinical trials related to Respiratory Distress Syndrome.

Filter by:

NCT ID: NCT05933291 Completed - Covid19 Clinical Trials

Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS

Start date: September 24, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about the effect of steroid therapy in patients with COVID-19 ARDS. The main questions it aims to answer are: - Differences between patients with COVID-19 ARDS before and after steroid treatment in BALF single cell landscape, as well as patients with different prognosis. - Differences between COVID-19 and non COVID-19 ARDS patients in BALF single cell landscape. Participants will Choose whether to use or not to utilize steroid treatment based on conditions.

NCT ID: NCT05905042 Completed - Mortality Clinical Trials

Follow-up of Recovery Condition in Survivors of Acute Respiratory Distress Syndrome

Start date: September 2014
Phase:
Study type: Observational [Patient Registry]

Hope to realize the recovery condition of ARDS survivors in Taiwan. It would be helpful not only to design the proper rehabilitation program but also to be a useful reference for the poor recovery patients to take hospice care if indicated.

NCT ID: NCT05882474 Completed - Clinical trials for COVID-19 Acute Respiratory Distress Syndrome

Correlation Between PaCO2 and Respiratory Effort in Patients With COVID-19 With Extracorporeal Membrane Oxygenation

Start date: December 1, 2022
Phase:
Study type: Observational

Excessive respiratory effort may cause self-inflicted lung injury (SILI) and inspiratory muscle injuries , stimulate desynchronization between the patient and ventilator , and worsen the perfusion of extrapulmonary organs . Appropriate respiratory drive and effort should be maintained during the treatment of patients with respiratory failure . In contrast, respiratory drive and effort are commonly increased in patients with COVID-19 pneumonia , and this phenomenon may persist in critically ill patients with COVID-19, even after receiving venovenous ECMO (vv-ECMO) support, owing to low pulmonary compliance and a high systemic inflammatory state . To reduce respiratory effort and drive, ICU physicians often administer high doses of sedative drugs, analgesics, and muscle relaxants. The prolonged use of high doses of these drugs can cause loss of the spontaneous cough reflex, which in turn impairs sputum drainage and eventually worsens pulmonary consolidation and lung infections. As the partial pressure of carbon dioxide in arterial blood (PaCO2) could affect the respiratory drive from the respiratory center (1), it has been shown that altering different levels of extracorporeal carbon dioxide removal in patients undergoing ECMO recovering from acute respiratory distress syndrome (ARDS) could alter respiratory drive. We hope to find a more appropriate target for maintaining PaCO2 to control respiratory effort in patients with COVID-19 undergoing ECMO.

NCT ID: NCT05866224 Completed - Clinical trials for COVID-19 Acute Respiratory Distress Syndrome

Telerehabilitation Program and Detraining in Patients With Post-COVID-19 Sequelae

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the effects of a 15-week home telerehabilitation program and a detraining period on cardiorespiratory fitness and muscular efficiency in patients with post-COVID-19 sequelae compared to a control group of COVID-19 patients. We hypothesize that cardiorespiratory fitness and muscular efficiency significantly improve in patients who carry out the home telerehabilitation program. However, the cardiorespiratory and muscular adaptations achieved and tolerance to exercise are lost over time as an effect of detraining.

NCT ID: NCT05816928 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Ventilation-Perfusion Matching in Early-stage Prone Position Ventilation

Start date: January 12, 2021
Phase:
Study type: Observational

Prone positioning has been widely used in critical care medicine to improve oxygenation in patients with acute respiratory distress syndrome (ARDS). This study aimed to compare the effect of pronation on lung ventilation-perfusion matching between COVID19-associated acute respiratory distress syndrome (CARDS) and ARDS from other etiologies (non-CARDS) using electrical impedance tomography (EIT).

NCT ID: NCT05796128 Completed - Clinical trials for Respiratory Distress Syndrome, Newborn

NIPPV vs.nCPAP During LISA Procedure

NIPAL
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The goal of this randomized controlled study is to compare the efficacy of using NIPPV versus NCPAP during the LISA procedure in very preterm infants. The main question it aims to answer is: • Does NIPPV during the LISA procedure decrease the need for a second dose of surfactant or the need of mechanical ventilation during the first 72 hours of life in comparison with NCPAP? Infants with gestational age between 25+0 and 31+6 weeks of gestation with RDS who do not require VM and treated with NCPAP and FiO2 >0.30 within the first 6 hours of life who received the first dose of caffeine will be eligible for enrollment in the study Participants will be randomized to receive surfactant with conventional LISA procedure, i.e. performed during NCPAP, or with LISA procedure performed during NIPPV.

NCT ID: NCT05794867 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Ultrasonic Weaning Criteria in Prolonged Ventilation

Start date: April 1, 2021
Phase:
Study type: Observational

compare and evaluate the effect of use of ultrasonic criteria of weaning versus the conventional ways of weaning in post-traumatic acute respiratory distress syndrome (ARDS) patients who were ventilated for a long time. And compare their effect on the duration of ICU stay.

NCT ID: NCT05780255 Completed - Quality of Life Clinical Trials

Quality of Life 1y and 2 y After VV-ECMO for COVID-19

Start date: April 20, 2021
Phase:
Study type: Observational

This study aims to investigate the quality of life and the outcome after veno-venous extracoporeal membrane oxygenation (ECMO) support fir severe acute respiratory syndrome (ARDS) in COVID-19 patients.

NCT ID: NCT05761626 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Mechanical Power and Ventilatory Ratio in ARDS

Start date: March 1, 2016
Phase:
Study type: Observational

Mechanical power (MP) and ventilatory ratio (VR) are variables associated with outcomes in patients with acute respiratory distress syndrome (ARDS). In respiratory setting, the optimization of MP should lead to an increase in VR. Therefore, the objectives of this study are: to assess the relationship between MP and VR and to compare the components of MP (ventilatory variables) according to a level of MP (17 J/minute) considered harmful.

NCT ID: NCT05736185 Completed - ARDS, Human Clinical Trials

Effect of Electric Impedance Tomography-Guided PEEP Titration

Start date: February 25, 2023
Phase: N/A
Study type: Interventional

Acute respiratory syndrome distress (ARDS) is a clinical common syndrome with high mortality. Mechanical ventilation (MV) is the cornerstone of management of ARDS but can lead to ventilator-induced lung injury. Positive end-expiratory pressure (PEEP), as one of main component of MV, has been widely used in the clinical practice. However, how to best set PEEP is still a difficult problem for moderate to severe ARDS patients. EIT, an imaging tool evaluating the regional ventilation distribution at the bedside, can achieve the individual PEEP selection for all mechanically ventilated patients. This article compared the effect of PEEP titrated guided by EIT with fraction of inspired oxygen (FiO2)-PEEP table on the ventilation-perfusion mismatch.